Published in Dermatology on January 01, 1997
T-lymphoblastic lymphoma with cutaneous involvement. World J Clin Cases (2015) 0.75
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A (2001) 7.19
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci (2001) 2.17
Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a multiobserver store-and-forward study on 20 skin specimens. Arch Dermatol (2002) 2.07
IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes (2001) 1.92
A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J (1994) 1.90
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab. Br J Dermatol (2013) 1.60
Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients. J Gen Virol (1992) 1.53
The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum. J Dermatolog Treat (2001) 1.50
Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides. Gene (1993) 1.47
Isolation in Europe of 69 M-like (serotype 8) human rotavirus strains with either subgroup I or II specificity and a long RNA electropherotype. Arch Virol (1990) 1.37
Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. J Immunol (1995) 1.32
European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol (2006) 1.30
Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol (2001) 1.28
Epitope discovery using peptide libraries displayed on phage. Trends Biotechnol (1994) 1.25
Structural requirements of endopolygalacturonase for the interaction with PGIP (polygalacturonase-inhibiting protein). Proc Natl Acad Sci U S A (2001) 1.21
The efficiency of walking of paraplegic patients using a reciprocating gait orthosis. Paraplegia (1995) 1.16
Cost of walking and locomotor impairment. J Electromyogr Kinesiol (1999) 1.15
A classification of psoriasis vulgaris according to phenotype. Br J Dermatol (2007) 1.13
Selection of biologically active peptides by phage display of random peptide libraries. Curr Opin Biotechnol (1996) 1.12
Face-to-face diagnosis vs telediagnosis of pigmented skin tumors: a teledermoscopic study. Arch Dermatol (1999) 1.11
Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study. Br J Dermatol (2013) 1.10
CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial. Br J Dermatol (2006) 1.10
Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library. Gene (1994) 1.08
Identification of biologically active peptides using random libraries displayed on phage. Curr Opin Biotechnol (1995) 1.07
Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer-aided diagnosis of 341 pigmented skin lesions: a comparative study. Br J Dermatol (2002) 1.05
Rapid detection of human rotavirus strains in stools by single-sandwich enzyme-linked immunosorbent assay systems using monoclonal antibodies. J Virol Methods (1989) 1.05
Identification of a human immunodominant B-cell epitope within the GRA1 antigen of Toxoplasma gondii by phage display of cDNA libraries. Int J Parasitol (2001) 1.04
Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems. Vascul Pharmacol (2006) 1.03
Teledermoscopy--results of a multicentre study on 43 pigmented skin lesions. J Telemed Telecare (2000) 1.01
Staphylococcal Scalded Skin Syndrome: Criteria for Differential Diagnosis from Lyell's Syndrome. Two Cases in Adult Patients. Ann Burns Fire Disasters (2006) 1.00
Serotype 3 human rotavirus strains with subgroup I specificity. J Clin Microbiol (1990) 0.99
Pyoderma vegetans and ulcerative colitis. Br J Dermatol (2001) 0.99
A 308-nm monochromatic excimer light in the treatment of palmoplantar psoriasis. J Eur Acad Dermatol Venereol (2006) 0.98
Dermoscopy of pigmented skin lesions. Eur J Dermatol (2001) 0.97
Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasis. Int J Immunopathol Pharmacol (2009) 0.96
The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. J Am Acad Dermatol (2001) 0.96
CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds. J Invest Dermatol (1998) 0.96
Biological therapies in the systemic management of psoriasis: International Consensus Conference. Br J Dermatol (2004) 0.95
Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. J Eur Acad Dermatol Venereol (2007) 0.95
Bullous SLE: response to methotrexate and relationship with disease activity. Lupus (2003) 0.95
Uptake and intracellular fate of phage display vectors in mammalian cells. Biochim Biophys Acta (1999) 0.95
The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum. Neuropharmacology (2006) 0.93
Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers. Br J Dermatol (2007) 0.93
Coexpression of bone sialoprotein (BSP) and the pivotal transcriptional regulator of osteogenesis, Cbfa1/Runx2, in malignant melanoma. Calcif Tissue Int (2003) 0.93
Moderate and severe plaque psoriasis: cost-of-illness study in Italy. Ther Clin Risk Manag (2008) 0.93
Targeted delivery of multivalent phage display vectors into mammalian cells. Biochim Biophys Acta (1999) 0.93
Systemic lupus erythematosus induced by Epstein-Barr virus infection. Br J Dermatol (2002) 0.93
Regional distribution of psoriasis in Italy. J Eur Acad Dermatol Venereol (2008) 0.92
Cutaneous eyebrow metastasis in a patient with primary gastric adenocarcinoma. Acta Derm Venereol (1994) 0.92
Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Eur J Immunol (1997) 0.92
Graham Little-Piccardi-Lassueur syndrome: effective treatment with cyclosporin A. Clin Exp Dermatol (2001) 0.91
Monoclonal antibodies that recognise filamentous phage: tools for phage display technology. Gene (1994) 0.91
Measurement and comparison of individual external doses of high-school students living in Japan, France, Poland and Belarus-the 'D-shuttle' project. J Radiol Prot (2015) 0.91
Treatment of erythrodermic psoriasis with etanercept. Br J Dermatol (2006) 0.90
The use of chemical peelings in the treatment of different cutaneous hyperpigmentations. Dermatol Surg (1999) 0.90
Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk. Leukemia (1997) 0.90
Histological features used in the diagnosis of melanoma are frequently found in benign melanocytic naevi. J Clin Pathol (2005) 0.90
Detection of hidden rhythms in surface EMG signals with a non-linear time-series tool. Med Eng Phys (2000) 0.89
Identification of human cytomegalovirus isolates by the polymerase chain reaction. Microbiologica (1990) 0.89
Central white scarlike patch: a dermatoscopic clue for the diagnosis of dermatofibroma. J Am Acad Dermatol (2000) 0.89
Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma. N Engl J Med (1999) 0.89
Electromyogram changes during sustained contraction after resistance training in women in their 3rd and 8th decades. Eur J Appl Physiol (2000) 0.89
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases. Br J Dermatol (2004) 0.89
Inflammatory effects on human lung epithelial cells after exposure to diesel exhaust micron sub particles (PM₁.₀) and pollen allergens. Environ Pollut (2011) 0.88
Comparison of various tests for the serological diagnosis of Trypanosoma equiperdum infection in the horse. Comp Immunol Microbiol Infect Dis (1981) 0.88
Amplitude and spectral characteristics of biceps Brachii sEMG depend upon speed of isometric force generation. J Electromyogr Kinesiol (2003) 0.88
Abnormal tactile temporal discrimination in psychogenic dystonia. Neurology (2011) 0.87
Etanercept at different dosages in the treatment of generalized pustular psoriasis: a case series. Dermatology (2008) 0.87
Betamethasone valerate dressing is non-inferior to calcipotriol-betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial. J Eur Acad Dermatol Venereol (2013) 0.86
Evolution of and risk factors for psychological distress in patients with psoriasis: the PSYCHAE study. Int J Immunopathol Pharmacol (2010) 0.86
Health-related quality of life in psoriasis: an analysis of Psocare project patients. G Ital Dermatol Venereol (2011) 0.86
Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma. J Eur Acad Dermatol Venereol (2006) 0.85
Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis. G Ital Dermatol Venereol (2012) 0.85
Immunization with phage-displayed mimotopes. Methods Enzymol (1996) 0.85
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts. Br J Dermatol (2003) 0.85
Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study Group. Haematologica (1999) 0.85
Histopathologic interobserver agreement on the diagnosis of melanocytic skin lesions with equivocal dermoscopic features: a pilot study. Tumori (2001) 0.85
A conformationally homogeneous combinatorial peptide library. J Mol Biol (1995) 0.84
Exercise induced muscle damage and recovery assessed by means of linear and non-linear sEMG analysis and ultrasonography. J Electromyogr Kinesiol (2001) 0.84
Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus. J Eur Acad Dermatol Venereol (2006) 0.84
Interobserver reproducibility of histological features in cutaneous malignant melanoma. J Clin Pathol (2005) 0.84
High-throughput genomics enhances tomato breeding efficiency. Curr Genomics (2009) 0.84
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. J Eur Acad Dermatol Venereol (2012) 0.84
Sawtooth pacing by real-time auxiliary power control in a tokamak plasma. Phys Rev Lett (2011) 0.84
"Clown nose" as a first manifestation of lung carcinoma. Acta Derm Venereol (1997) 0.84
Microsatellite instability and loss of heterozygosity in melanoma. J Invest Dermatol (1995) 0.83
Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab. J Eur Acad Dermatol Venereol (2008) 0.83
Sentinel lymphadenectomy in cutaneous melanoma. Tumori (2002) 0.83
Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus. Ann Hum Genet (2004) 0.83
3-O-methylfunicone, a metabolite of Penicillium pinophilum, inhibits proliferation of human melanoma cells by causing G(2) + M arrest and inducing apoptosis. Cell Prolif (2009) 0.82
Dermoscopy of pigmented skin lesions (Part II). Eur J Dermatol (2001) 0.82
Structure of the Saccharomyces cerevisiae gene encoding tRNAIle (IAU). Nucleic Acids Res (1987) 0.82
Expression of bovine rotavirus neutralization antigen in Escherichia coli. J Gen Virol (1987) 0.82
Actinic keratosis treated with an immune response modifier: a case report of six patients. Clin Exp Dermatol (2003) 0.82
ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serum. Eur J Biochem (2001) 0.82